Vimarsana
Biggest News Aggregation in the World

Page 2 - Agepha Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Agepha Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Agepha Pharma Today - Breaking & Trending Today

A Price Jump From Pennies to $20/Pill for the Same Drug - Vimarsana News

A Price Jump From Pennies to $20/Pill for the Same Drug

Drug pricing should be subject to stricter regulation

No Reduction in AF After Noncardiac Surgery With Colchicine: COP-AF - Vimarsana News

No Reduction in AF After Noncardiac Surgery With Colchicine: COP-AF

COP-AF trial results showed no significant reduction in co-primary endpoints of clinically important AF or myocardial injury after noncardiac thoracic surgery, although there were positive trends.

Could Colchicine Replace Aspirin After PCI for ACS? - Vimarsana News

Could Colchicine Replace Aspirin After PCI for ACS?

Aspirin is typically given after PCI for acute coronary syndrome but can lead to major bleeding. Colchicine appears to be safer and may be equally efficacious, pilot data suggest.

Addressing Inflammation and Role of Colchicine in ASCVD, with Michael J. Blaha, MD, MPH - Vimarsana News

Addressing Inflammation and Role of Colchicine in ASCVD, with Michael J. Blaha, MD, MPH

Michael J. Blaha, MD, MPH, discusses his interpretation of the growing data detailing the role of inflammation as a driver of cardiovascular risk and how clinicians can identify patients who stand to benefit most from colchicine 0.5 mg tablets.

Americans pip Dutch to the post in heart medicine registration - Vimarsana News

Americans pip Dutch to the post in heart medicine registration

Americans pip Dutch to the post in heart medicine registration